Log in

Relevant bibliographies by topics / Pricing – France / Journal articles

To see the other types of publications on this topic, follow the link: Pricing – France.

Journal articles on the topic 'Pricing – France'

Author: Grafiati

Published: 10 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pricing – France.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Silberztein, Caroline. "France: New Transfer Pricing Rules." Intertax 24, Issue 6/7 (1996): 246–48. http://dx.doi.org/10.54648/taxi1996046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Le Pen, Claude. "Drug Pricing and Reimbursement in France." PharmacoEconomics 10, Supplement 2 (1996): 26–36. http://dx.doi.org/10.2165/00019053-199600102-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zielke, Rainer. "Transfer Pricing of Mayor EC Member Countries with Reference to the 2014 Corporate Income Tax Burden of the Thirty-Four OECD Member Countries Germany, France, United Kingdom, and Italy Compared." EC Tax Review 23, Issue 6 (2014): 332–51. http://dx.doi.org/10.54648/ecta2014032.

Full text

Abstract:

In the February 2014 issue of the EC Tax Review, the author compared the anti-avoidance legislation in the mayor EC Member Countries Germany, France, United Kingdom and Italy and suggested some international tax planning strategies - without regard to transfer pricing (part 1). The author now considers transfer pricing involving these mayors EC Member Countries Germany, France, United Kingdom, and Italy and suggests further transfer pricing strategies also with regard to the up-to-date CIT rates in OECD countries (part 2). As stated, despite continuous instability in the European Community (EC

APA, Harvard, Vancouver, ISO, and other styles

4

Carricano, Manu. "Pricing myopia: do leading companies capture the full value of their pricing strategies?" Management Decision 52, no. 1 (2014): 159–78. http://dx.doi.org/10.1108/md-03-2013-0184.

Full text

Abstract:

Purpose – Many companies lack insights or fact-based support for the pricing decisions they make in an increasingly complex environment. In order to optimize their pricing process, managers need to identify key indicators that may influence the performance of their decisions. The purpose of this paper is to report an investigation of pricing determinants in large companies manufacturing capital goods in France. First a conceptual framework is proposed, in order to fill several gaps identified in the literature on pricing practices and more precisely by operating a distinction between environme

APA, Harvard, Vancouver, ISO, and other styles

5

Hellier, Emmanuelle. "Locally uniform water utility pricing. Social and economic issues in an emergent policy in France and Italy." Geopolitical, Social Security and Freedom Journal 1, no. 1 (2018): 152–70. http://dx.doi.org/10.2478/gssfj-2018-0008.

Full text

Abstract:

Abstract Over the past twenty years, the principles of ‘full-cost recovery’ and ‘the user pays’ have become prominent in water utility pricing across the EU. At the same time, uniform pricing has been introduced by local authorities to boost equality between users in a given territory. Two case studies in France and Italy reveal different processes, depending upon the institutional setting, though in both cases EU regulations exert increasing influence on the water pricing structure. A literature review and study of specific documentation was used to prepare about thirty semi-directive intervi

APA, Harvard, Vancouver, ISO, and other styles

6

Friedeberg-Steward, Beatrix. "Pricing and Reimbursement of Pharmaceutical Products in France." Drug Information Journal 34, no. 4 (2000): 1201–5. http://dx.doi.org/10.1177/009286150003400427.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Pandey, Asheesh, Sanjay Sehgal, Amiya Kumar Mohapatra, and Pradeepta Kumar Samanta. "Equity market anomalies in major European economies." Investment Management and Financial Innovations 18, no. 2 (2021): 245–60. http://dx.doi.org/10.21511/imfi.18(2).2021.20.

Full text

Abstract:

This paper investigates five leading equity market anomalies – size, value, momentum, profitability, and asset growth, for four Western European markets, namely, Germany, France, Italy and Spain, from January 2002 to March 2018. The study tests whether these anomalies reverse under different macro-economic uncertainty conditions, and evaluates if strategies based on time diversification can be formed using these equity market anomalies. Market anomalies were tested using four major asset pricing models – the Capital Asset Pricing Model, the Fama-French three-factor model, the Carhart model, an

APA, Harvard, Vancouver, ISO, and other styles

8

Kilani, Moez, Ngagne Diop, and Daniel De Wolf. "A Multimodal Transport Model to Evaluate Transport Policies in the North of France." Sustainability 14, no. 3 (2022): 1535. http://dx.doi.org/10.3390/su14031535.

Full text

Abstract:

We developed a passenger transport model for the North of France and used it to discuss the impacts of some policies focusing on the limitations of polluting gas emissions and congestion. The model is calibrated for the North of France and includes both urban and intercity trips. Four transport modes are considered: walking, biking, public transport and private cars. To some extent, the combination of these modes is possible. The model is calibrated to match mode shares and the dynamic of congestion along a full day. The simulations are conducted within the MATSim framework. We evaluate the im

APA, Harvard, Vancouver, ISO, and other styles

9

Illescas, Manzano María Dolores, Pérez Manuel Sánchez, and Puertas Sergio Martínez. "Why pricing hotel can have differences according to the country in which it is found?" Estudios de Economía Aplicada 37, no. 1 (2019): 122–37. https://doi.org/10.5281/zenodo.10622416.

Full text

Abstract:

Our study consists of comparing 3,084 hotels in different cities of two countries (Spain and France) and identifying which are determinate factors that most influence in fixing price hotel of each country, analyzing their similarities and differences. We use hedonic pricing models based on least squares estimation (OLS) and quantile regression estimation. The results obtained by both OLS and quantile regression confirm that hotel category is a stronger quality signal in France than in Spain while eWOM has more influence on the room price in Spain than in France. In both countries, the effect o

APA, Harvard, Vancouver, ISO, and other styles

10

Croguennec-Le Saout, Hélène. "Financial Reform of Public Policy on Ageing in France and the Persistent Invisibilization of Caregivers." Femina Politica – Zeitschrift für feministische Politikwissenschaft 33, no. 2-2024 (2024): 59–75. http://dx.doi.org/10.3224/feminapolitica.v33i2.05.

Full text

Abstract:

This article aims to examine the financing of public policy on ageing in France with a focus on gender. Our research draws from an analysis of the pricing system applied to nursing homes for dependent elderly people (établissement hébergement pour personnes âgées dépendantes – EHPADs), last reformed in 2015 by the Adaptation of Society to Ageing Act. In this paper, we question the roles reserved to women as employees of the welfare state, caregivers, and citizens, in light of the representations driven by the pricing system. Our work draws mainly from a survey conducted in 2023 in four care ho

APA, Harvard, Vancouver, ISO, and other styles

11

Pelc, Alain, and Jean-Philippe Castan. "New Developments in Pricing and Drug Reimbursement in France." PharmacoEconomics 6, Supplement 1 (1994): 28–35. http://dx.doi.org/10.2165/00019053-199400061-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Garcia, Serge, and Arnaud Reynaud. "Estimating the benefits of efficient water pricing in France." Resource and Energy Economics 26, no. 1 (2004): 1–25. http://dx.doi.org/10.1016/j.reseneeco.2003.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Rodrigues, J., D. Bartels, L. Gundtoft, M. P. Planel, J. P. Sales, and T. A. Behnk. "PNS116 COMPARATIVE PRICING POLICY ANALYSIS BETWEEN DENMARK AND FRANCE." Value in Health 22 (November 2019): S781. http://dx.doi.org/10.1016/j.jval.2019.09.2018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

GRAND, H., A. L. Samson, and M. Aulois-Griot. "Orphan Drug Pricing In France: Influence of Main Factors." Value in Health 17, no. 7 (2014): A534. http://dx.doi.org/10.1016/j.jval.2014.08.1702.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Megerlin, Francis, and François Lhoste. "Innovation et réglementation du pricing des dispositifs médicaux en France." Santé Décision Management 12, no. 1-4 (2009): 69–84. http://dx.doi.org/10.3166/sdm.12.69-84.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Ben Ali, Chiraz, and Cédric Lesage. "Audit pricing and nature of controlling shareholders: Evidence from France." China Journal of Accounting Research 6, no. 1 (2013): 21–34. http://dx.doi.org/10.1016/j.cjar.2012.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Natz, Alexander, and Marie-Geneviève Campion. "Pricing and reimbursement of innovative pharmaceuticals in France and the new healthcare reform." Farmeconomia. Health economics and therapeutic pathways 13, no. 2 (2012): 49–60. http://dx.doi.org/10.7175/fe.v13i2.270.

Full text

Abstract:

Over the last years, many cost-containment measures were implemented by the government leading to drastic price-cuts. New paradigms and healthcare models are emerging and health technology assessments are increasingly taken into consideration. France has the second biggest rank in terms of healthcare spending after the US. Pharmaceuticals represented around 19% of the budget of the Health Insurance funds in 2009. In France, innovative pharmaceuticals have been subject for a long-time to price-control and cost-containment measures. The present review provides a general description of the French

APA, Harvard, Vancouver, ISO, and other styles

18

Sánchez, Pérez Manuel, Manzano María Dolores Illescas, and Puertas Sergio Martínez. "Modeling hotel room pricing: A multi-country analysis." International Journal of Hospitality Management 79 (January 23, 2025): 89–99. https://doi.org/10.5281/zenodo.14728067.

Full text

Abstract:

In the current tourism landscape, pricing decisions reemerge as a key concern for hoteliers. This study examines the impact of specific factors associated with hotels, customers’ experience, and competition on hotel pricing in different countries. Certain features of market behavior can distort expected prices, such as asymmetric information, differences in hotel categorization, hotels spatial concentration or electronic word-of-mouth (eWOM). In order to understand the determinants of pricing and to obtain a complete characterization of them, the present study applies quantile regression

APA, Harvard, Vancouver, ISO, and other styles

19

Villemur, L., J. Cortes, and P. Gaugy. "HTA289 Analysis of the Reimbursement and Pricing of Vaccines in France." Value in Health 27, no. 12 (2024): S411. https://doi.org/10.1016/j.jval.2024.10.2114.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Colla, Enrico, and Paul Lapoule. "Banning below‐cost resale in France: the impact on pricing decisions." International Journal of Retail & Distribution Management 36, no. 10 (2008): 746–58. http://dx.doi.org/10.1108/09590550810900973.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Karamti, Chiraz, and Lukasz Grzybowski. "Hedonic study on mobile telephony market in France: pricing–quality strategies." NETNOMICS: Economic Research and Electronic Networking 11, no. 3 (2010): 255–89. http://dx.doi.org/10.1007/s11066-010-9049-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Montginoul, Marielle. "Analysing the Diversity of Water Pricing Structures: The Case of France." Water Resources Management 21, no. 5 (2006): 861–71. http://dx.doi.org/10.1007/s11269-006-9104-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Jai Pal Sharma, Pooja. "Mapping the Intellectual Structure of Asset Pricing: A Bibliometric Study." Review of Finance and Banking 16, no. 1 (2024): 57–71. http://dx.doi.org/10.24818/rfb.23.16.01.05.

Full text

Abstract:

This paper presents a bibliometric analysis of research on asset pricing and identifies and highlights the most significant authors, keywords, articles, and journals based on a systematic literature review and Bibliometric analysis of 915 documents published over 33 years (1989-2022), obtained from the web of science database, to discover the noticeable landscape and research horizons in the field of asset pricing theory. This descriptive study demonstrates an upward trend in ”asset pricing’ papers in business and finance journals. According to the report, the United States is the leading cont

APA, Harvard, Vancouver, ISO, and other styles

24

RAIMOND, VÉRONIQUE C., WILLIAM B. FELDMAN, BENJAMIN N. ROME, and AARON S. KESSELHEIM. "Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation." Milbank Quarterly 99, no. 1 (2021): 240–72. http://dx.doi.org/10.1111/1468-0009.12507.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dubois, Pierre, and Laura Lasio. "Identifying Industry Margins with Price Constraints: Structural Estimation on Pharmaceuticals." American Economic Review 108, no. 12 (2018): 3685–724. http://dx.doi.org/10.1257/aer.20140202.

Full text

Abstract:

We develop a structural model to investigate the effects of pharmaceutical price regulation on demand and on manufacturers’ price-setting behavior in France. We estimate price-cost margins in a regulated market with price constraints and infer whether these constraints are binding, exploiting cost restrictions across drugs, which come from observing the same drugs in potentially price-constrained markets (France) and in markets where prices are unregulated (United States and Germany). Our counterfactual simulations suggest that price constraints generated modest savings for anti-ulcer drugs in

APA, Harvard, Vancouver, ISO, and other styles

26

Gilard, Martine, Frédérique Debroucker, Claude Dubray, et al. "Scientific Evaluation and Pricing of Medical Devices and Associated Procedures in France." Therapies 68, no. 4 (2013): 201–8. http://dx.doi.org/10.2515/therapie/2013036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Niklitschek, T., A. E. Williams, and M. Storer. "PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France." Value in Health 15, no. 7 (2012): A452. http://dx.doi.org/10.1016/j.jval.2012.08.1424.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Tazi, N., and Y. Bouzidi. "Evolution of wind energy pricing policies in France: Opportunities and new challenges." Energy Reports 6 (February 2020): 687–92. http://dx.doi.org/10.1016/j.egyr.2019.09.050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Gaugy, P., and J. Cottin. "HTA136 Analysis of the Reimbursement and Pricing of Hybrid Medicines in France." Value in Health 26, no. 12 (2023): S345. http://dx.doi.org/10.1016/j.jval.2023.09.1820.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Herrenschmidt, Fleur. "The French Competition Council and Parallel Trade in the Pharmaceutical Industry: A Step Ahead of EU Case Law?" World Competition 31, Issue 2 (2008): 235–57. http://dx.doi.org/10.54648/woco2008019.

Full text

Abstract:

This article focuses on the French competition authorities’ analysis of the validity, from a competition law perspective, of various distribution policies implemented by pharmaceutical companies in France which aimed to reduce parallel trade. In France, the pharmaceutical sector is notably characterised by: the existence of a specific “export–only” wholesaler status; numerous but imprecise public service obligations on “fullline” wholesalers which in particular require that they permanently supply all pharmacists with all products in a given time period; a strict capping of end retail prices a

APA, Harvard, Vancouver, ISO, and other styles

31

Kockaya, Guvenc, Kagan Atikeler, Esin Tuna, et al. "Results of reference pricing and reimbursement discount rate schemes of Turkey." Farmeconomia. Health economics and therapeutic pathways 14, no. 2 (2013): 99–103. http://dx.doi.org/10.7175/fe.v14i2.473.

Full text

Abstract:

OBJECTIVES: General Directorate of Pharmaceuticals and Pharmacy (IEGM) is responsible for setting all prices for human medicinal products. The reference pricing system is used for setting these prices. Reference countries are reviewed annually and may be subject to certain alterations. There were 5 reference countries in 2009: Spain, Italy, Germany, France and Greece. The aim of this study is to show the distribution of reference countries which were used for reference pricing.METHODS: The price list of pharmaceuticals which was published by IEGM on 15.04.2011 was used for analysis. Distributi

APA, Harvard, Vancouver, ISO, and other styles

32

Pavelková, Eva Mazegue, and Iva Živělová. "Pricing Electric Power in the Czech Republic and in Selected Countries." Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis 64, no. 3 (2016): 1001–11. http://dx.doi.org/10.11118/actaun201664031001.

Full text

Abstract:

This paper focuses on state intervention in the pricing of electricity from renewable power sources in the Czech Republic when compared with the pricing in the Slovak Republic, Germany, France and Italy. In these countries the state intervention is implemented in different forms, but the critical part of the price is regulated everywhere by the state. The price of electricity is determined by its production costs, which depend on the source from which electricity is produced. The highest cost of electricity is required to generate renewable energy, particularly solar power, while the lowest co

APA, Harvard, Vancouver, ISO, and other styles

33

Myungsu Hong. "A Study on the Predatory Pricing in EU Competition Law - France Telecom Case -." KYUNGPOOK NATIONAL UNIVERSITY LAW JOURNAL ll, no. 59 (2017): 259–84. http://dx.doi.org/10.17248/knulaw..59.201708.259.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Carval, G., M. Planel, and T. Zaccherini. "PMD160 - PRICING OF REIMBURSED MEDICAL DEVICES IN FRANCE: WHAT FACTORS IMPACT DECISION-MAKING?" Value in Health 21 (October 2018): S270. http://dx.doi.org/10.1016/j.jval.2018.09.1609.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Moutie, A. S., J. P. Sales, M. P. Planel, and J. Rodrigues. "PDG57 DRUG PRICING PREDICTABILITY IN FRANCE: WHICH MANAGED ENTRY AGREEMENT SUITS THE BEST?" Value in Health 22 (November 2019): S606. http://dx.doi.org/10.1016/j.jval.2019.09.1071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Rakhmayil, Sergiy. "Dating Capital Market Integration In The EMU." International Business & Economics Research Journal (IBER) 10, no. 3 (2011): 63. http://dx.doi.org/10.19030/iber.v10i3.4102.

Full text

Abstract:

This paper analyzes the effect of the Euro on structural breaks in financial market variables in a sample of three EMU (France, Germany, Netherlands) and two non-EMU (U.K. and Switzerland) countries from March 1984 to November 2002. We identify two dates when integration-related structural breaks occurred in European asset pricing; the first in 1986 affected all sample countries whereas the second in 2000 affected only the EMU countries and could be attributed to the adoption of Euro in 1999.

APA, Harvard, Vancouver, ISO, and other styles

37

Montginoul, M., J.-D. Rinaudo, Y. Lunet de Lajonquière, P. Garin, and J.-P. Marchal. "Simulating the impact of water pricing on households behaviour: the temptation of using untreated water." Water Policy 7, no. 5 (2005): 523–41. http://dx.doi.org/10.2166/wp.2005.0031.

Full text

Abstract:

Recent studies on urban water demand have suggested that the water price increase observed during the last ten years in France has led to a reduction in the consumption of urban water by households. Whereas certain households have reduced their water consumption, others have turned to substitute water resources (collection of rainwater, borehole drilling, wells supplied with untreated mains water, grey water recycling systems, etc.). This article presents the results of a case study, which describes and analyses the phenomenon of resorting to untreated groundwater as a complement to or a subst

APA, Harvard, Vancouver, ISO, and other styles

38

Rodwin, Marc A. "Common Pharmaceutical Price and Cost Controls in the United Kingdom, France, and Germany: Lessons for the United States." International Journal of Health Services 51, no. 3 (2021): 379–91. http://dx.doi.org/10.1177/0020731421996168.

Full text

Abstract:

To identify pharmaceutical spending-control options for the United States, we analyzed the policies of the United Kingdom, France, and Germany, which encourage drugmakers to undertake innovations that improve health while controlling spending. Their main strategies today include: using legislation to set default rules that increase the insurer's bargaining position, employing health technology assessment that measures cost-effectiveness or comparative effectiveness and caps the purchase or reimbursement price, setting a single maximum price for similar drugs (reference group pricing), capping

APA, Harvard, Vancouver, ISO, and other styles

39

Sukmadilaga, Citra, Jose Christian Santoso, and Erlane K. Ghani. "Can Accounting Value Relevance and Pricing Error Influence Stock Price of High-Technology Service Enterprises?" Economies 11, no. 2 (2023): 48. http://dx.doi.org/10.3390/economies11020048.

Full text

Abstract:

This study examines whether relevant accounting ratios influence the stock prices of high-technology service enterprises in five countries, namely, the United States, Japan, China, the United Kingdom, and France. Subsequently, this study determines the existence of pricing error (if any) between the intrinsic value and the market value of the stock price due to the accounting ratios. Content analysis was performed on the annual reports of 326 high-technology service enterprises to determine the effect of three accounting ratios, namely diluted earnings per share, revenue per share, and book va

APA, Harvard, Vancouver, ISO, and other styles

40

Boutouria, Nahla, Salah Ben Hamad, and Imed Medhioub. "Option Valuation in the Presence of Market Sentiment: Application to Listed Companies in the CAC40 Index." Cognizance Journal of Multidisciplinary Studies 1, no. 9 (2021): 1–11. http://dx.doi.org/10.47760/cognizance.2021.v01i09.001.

Full text

Abstract:

Asset pricing theory based on rationality was widely criticized in literature. Indeed, the non-inclusion of investor behavior and assuming market efficiency led to the weaknesses of option valuation through the traditional Black and Scholes model (1973). In this paper we examine the effect of the inclusion of investor behavior in the option pricing model. We test whether the Black and Scholes model in presence of sentiment behavior can lead to an improvement of the calculation of call price. Using daily data of 30 listed companies of France in the CAC40 index for the period June 18, 2009 to Ma

APA, Harvard, Vancouver, ISO, and other styles

41

Nahla, Boutouria, Ben Hamad Salah, and Medhioub Imed. "Option Valuation in the Presence of Market Sentiment: Application to Listed Companies in the CAC40 Index." Cognizance Journal of Multidisciplinary Studies 1, no. 9 (2021): 1–11. https://doi.org/10.47760/cognizance.2021.v01i09.001.

Full text

Abstract:

Asset pricing theory based on rationality was widely criticized in literature. Indeed, the non-inclusion of investor behavior and assuming market efficiency led to the weaknesses of option valuation through the traditional Black and Scholes model (1973). In this paper we examine the effect of the inclusion of investor behavior in the option pricing model. We test whether the Black and Scholes model in presence of sentiment behavior can lead to an improvement of the calculation of call price. Using daily data of 30 listed companies of France in the CAC40 index for the period June 18, 2009 to Ma

APA, Harvard, Vancouver, ISO, and other styles

42

Gregg, Emily, Karina Watts, Charlotte Graham, and Stuart Mealing. "PD195 Variation In Decision-Making And Market Access Routes For Vaccines: Insights From Seven Countries." International Journal of Technology Assessment in Health Care 40, S1 (2024): S167. https://doi.org/10.1017/s0266462324004173.

Full text

Abstract:

IntroductionQuick and equitable market access to vaccines is a global priority. However, market access routes for vaccines are complex and differ from those for pharmaceuticals. Furthermore, there is variation in decision-making between countries due to local requirements. This work aimed to increase awareness of the key elements of these pathways and the stakeholders involved in European Union (EU) and non-EU countries.MethodsPragmatic desk-based research was undertaken in November 2023 to explore key elements of the market access pathways for vaccines and how these differ between countries.

APA, Harvard, Vancouver, ISO, and other styles

43

Leurent, Fabien, and Sheng Li. "Between Pricing and Investment, What Mobility Policies Would Be Advantageous for Île-de-France?" Journal of Advanced Transportation 2020 (December 19, 2020): 1–13. http://dx.doi.org/10.1155/2020/8859913.

Full text

Abstract:

This article provides a prospective study of mobility policies for the private car and public transit (PT) modes of transportation in the Paris Ile-de-France region. Different economic instruments are considered: pricing of car traffic or transit service, subsidizing PT, and investment in PT to improve service quality. Policy scenarios are defined and assessed according to multiple criteria: users’ benefits, PT production costs and fare revenues, public subsidies, and environmental damage both local (air pollution) and global (carbon emissions). The social, economic, and environmental impacts

APA, Harvard, Vancouver, ISO, and other styles

44

Pandey, Asheesh, and Rajni Joshi. "Examining Asset Pricing Anomalies: Evidence from Europe." Business Perspectives and Research, July 30, 2021, 227853372110257. http://dx.doi.org/10.1177/22785337211025712.

Full text

Abstract:

We examine five important asset pricing anomalies, namely, size, value, momentum, profitability, and investment rate to evaluate their efficacy in major West European economies, that is, France, Germany, Italy, and Spain. We employ four prominent asset pricing models, namely Capital Asset Pricing Model (CAPM), Fama–French three-factor (FF3) model, Carhart model and Fama–French five-factor (FF5) model to evaluate whether portfolio managers can create trading strategies to generate risk-adjusted extra normal returns for their investors. We also examine the prominent anomalies which pass the test

APA, Harvard, Vancouver, ISO, and other styles

45

Douvier, P. J., and X. Daluzeau. "New Transfer Pricing Documentation Obligations for Large Companies." International Transfer Pricing Journal 21, no. 3 (2014). http://dx.doi.org/10.59403/3f0zjn2.

Full text

Abstract:

Several provisions – such as new requirements regarding transfer pricing documentation and accounting information to provide in the course of a tax audit – were enacted in France at the end of 2013. These measures will increase the transparency of large companies vis-à-vis the French tax authorities. They will also trigger additional constraints for large companies and confirm that transfer pricing will remain a priority in coming tax audits in France.

APA, Harvard, Vancouver, ISO, and other styles

46

"Reference pricing to be introduced in France." PharmacoEconomics & Outcomes News 207, no. 1 (1999): 11. http://dx.doi.org/10.1007/bf03274919.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Pelen, F. "Reimbursement and Pricing of Drugs in France." HEPAC Health Economics in Prevention and Care, March 1, 2000, 20–23. http://dx.doi.org/10.1007/s101980070019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

"No agreement on Bronchitol pricing in France." PharmacoEconomics & Outcomes News 686, no. 1 (2013): 11. http://dx.doi.org/10.1007/s40274-013-0701-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

"France cuts novel pricing deal for celecoxib." PharmacoEconomics & Outcomes News 299, no. 1 (2001): 12. http://dx.doi.org/10.1007/bf03269170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Le Bris, David, Olivier Gergaud, Debrah C. Meloso, and Ronan Tallec. "Buyback option pricing in Old Regime France." SSRN Electronic Journal, 2024. http://dx.doi.org/10.2139/ssrn.4824006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!